Company’s 36-month beta value is 0.37.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OGEN is 3.95M, and currently, short sellers hold a 0.90% ratio of that floaft. The average trading volume of OGEN on May 08, 2024 was 89.17K shares.
OGEN) stock’s latest price update
Oragenics Inc (AMEX: OGEN)’s stock price has gone rise by 24.07 in comparison to its previous close of 1.08, however, the company has experienced a 29.47% increase in its stock price over the last five trading days. InvestorPlace reported 2024-02-28 that Oragenics (NYSEMKT: OGEN ) stock is falling on Wednesday after the antibiotics development company announced details of a public offering for its shares. Oragenics is selling 1.4 million shares of OGEN stock for $1.50 each.
OGEN’s Market Performance
OGEN’s stock has risen by 29.47% in the past week, with a monthly rise of 0.75% and a quarterly drop of -45.31%. The volatility ratio for the week is 11.99% while the volatility levels for the last 30 days are 9.88% for Oragenics Inc The simple moving average for the past 20 days is 20.91% for OGEN’s stock, with a -58.30% simple moving average for the past 200 days.
OGEN Trading at -0.32% from the 50-Day Moving Average
After a stumble in the market that brought OGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.69% of loss for the given period.
Volatility was left at 9.88%, however, over the last 30 days, the volatility rate increased by 11.99%, as shares surge +5.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -57.59% lower at present.
During the last 5 trading sessions, OGEN rose by +29.47%, which changed the moving average for the period of 200-days by -67.40% in comparison to the 20-day moving average, which settled at $1.1118. In addition, Oragenics Inc saw -76.18% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OGEN starting from Telling Fred, who sale 3,500 shares at the price of $3.57 back on Nov 30 ’23. After this action, Telling Fred now owns 38,345 shares of Oragenics Inc, valued at $12,488 using the latest closing price.
Stock Fundamentals for OGEN
Current profitability levels for the company are sitting at:
- -282.35 for the present operating margin
- -292.98 for the gross margin
The net margin for Oragenics Inc stands at -547.08. The total capital return value is set at -3.36. Equity return is now at value -255.36, with -209.44 for asset returns.
Based on Oragenics Inc (OGEN), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -22.61. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -347.53.
Currently, EBITDA for the company is -10.64 million with net debt to EBITDA at 0.3. When we switch over and look at the enterprise to sales, we see a ratio of 75.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.15.
Conclusion
In a nutshell, Oragenics Inc (OGEN) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
